Chronic kidney disease stage 5
1 paper
- Humans1
Trial sponsors
1 trialPhase 360 people
Latest
1 in 12 monthsDiabetes, Obesity & Metabolism
Kidney Outcomes With GLP-1 Receptor Agonists and Tirzepatide Versus Finerenone in Type 2 Diabetes and Chronic Kidney Disease: A Real-World Cohort Study
Cohort study of 4,554 peopleGLP-1 receptor agonists